Tag: Canntab Therapeutics

December 23, 2019

Canntab Submits Site Evidence Package to Obtain LP Status

Canntab Therapeutics announced it has submitted its site evidence package to Health Canada for approval of their licence producer status.
August 5, 2019

Cannabis Investment: Canadian Cannabis Stocks

Are you interested in cannabis investment? Here's a list of Canadian marijuana stocks for investors to reference.
July 31, 2019

CSE Marijuana Stocks

More and more marijuana stocks are joining the Canadian Securities Exchange. Here's a breakdown of the companies listed there.
July 24, 2019

US Cannabis Stocks

Canadian companies dominate the global cannabis market, but US cannabis stocks show much potential for savvy investors.
March 4, 2019

Canntab Discusses Hemp Supply Agreement with FSD Pharma and Canada’s Second Wave of Cannabis Legalization

Canntab Therapeutics (CSE:PILL, OTC:CTABF, FSE:TBF1) CFO Richard Goldstein was featured in an interview on Midas Letter.
February 28, 2019

Canntab Enters into Five Year Supply and Loan Agreement with FSD Pharma and World Class Extractions on Organic Hemp Deal

Canntab Therapeutics (CSE:PILL, OTC:CTABF, FSE:TBF1) (“Canntab” or the “Company”) is pleased to announce that it has entered into a supply and...
February 20, 2019

Canntab Provides Corporate Update

Canntab Therapeutics (CSE:PILL) (OTC:CTABF, FSE:TBF1) (“Canntab” or the “Company”) is pleased to provide an update on a number of significant...